Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).
CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.